Digital Game for High Blood Pressure
(N-SCDG Trial)
Trial Summary
What is the purpose of this trial?
This study evaluates a sensor-controlled digital game (SCDG) to motivate self-management behaviors of physical activity in Native American adults with hypertension (HTN). Half of the participants will receive the SCDG app and physical activity sensors and the other half will receive only the physical activity sensors. Native American participants with hypertension (HTN) in the sensor controlled digital game intervention group will show increased PA behaviors; improved HTN knowledge, self-care behaviors, self-efficacy, motivation, and quality of life (QoL); and larger reduction in systolic and diastolic blood pressure and cardiac hospitalizations at baseline,3 months, and 6 months as compared to participants in the sensor-only control group.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. It seems likely that you can continue your antihypertensive medication, as the study includes participants who are already on such medications.
What data supports the effectiveness of the treatment Sensor-controlled digital game for high blood pressure?
Is the digital game treatment safe for humans?
How does the sensor-controlled digital game treatment for high blood pressure differ from other treatments?
Research Team
Kavita Radhakrishnan, PhD
Principal Investigator
The University of Texas Austin
Eligibility Criteria
This trial is for Native American adults living in the southeastern U.S. who have high blood pressure, measured as systolic BP ≥140mm Hg or diastolic BP ≥90mm Hg twice, or those on blood pressure medication. Participants must be over 18, able to walk independently without assistance, and pass a basic cognitive test.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the sensor-controlled digital game (SCDG) app and physical activity sensors or only the physical activity sensors
Follow-up
Participants are monitored for changes in hypertension self-efficacy, quality of life, and blood pressure control
Treatment Details
Interventions
- Sensor-controlled digital game (Behavioural Intervention)
- Sensor only (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas at Austin
Lead Sponsor
Dr. Elly Barry
University of Texas at Austin
Chief Medical Officer
MD from Harvard Medical School
Dr. Brian Windsor
University of Texas at Austin
Chief Executive Officer since 2023
PhD in Molecular Biology from the University of Texas at Austin
National Institutes of Health (NIH)
Collaborator
Dr. Jeanne Marrazzo
National Institutes of Health (NIH)
Chief Medical Officer
MD from University of California, Los Angeles
Dr. Jay Bhattacharya
National Institutes of Health (NIH)
Chief Executive Officer
MD, PhD from Stanford University
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Dr. Gary H. Gibbons
National Heart, Lung, and Blood Institute (NHLBI)
Chief Executive Officer since 2012
MD from Harvard Medical School
Dr. James P. Kiley
National Heart, Lung, and Blood Institute (NHLBI)
Chief Medical Officer since 2011
MD from University of California, San Francisco